» Articles » PMID: 11857079

Direct Repression of the Mcl-1 Promoter by E2F1

Overview
Journal Oncogene
Date 2002 Feb 22
PMID 11857079
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

E2F1 induces apoptosis via both p53-dependent and p53-independent mechanisms. The direct targets in the p53-independent pathway remain enigmatic; however, the induction of this pathway does not require the transactivation domain of E2F1. Using cells that are defective in p53 activation, we show that E2F1 potently represses the expression of Mcl-1--an anti-apoptotic Bcl-2 family member whose depletion results in apoptosis. We also show that this transcriptional repression is direct and dependent upon E2F1's DNA-binding domain, but does not require the transactivation domain of E2F1. Consistent with this DNA binding requirement of E2F1 to repress Mcl-1, we show that E2F1 binds to the Mcl-1 promoter both in vitro and in vivo, and have identified the DNA element (-143/-117) within this promoter that is required for E2F1 binding and repression. Additionally, cell lines constitutively expressing Mcl-1 are resistant to E2F1-mediated apoptosis--suggesting that Mcl-1 downregulation is a necessary event in the p53-independent apoptotic process. Thus, we identify a p53 family-independent mechanism of E2F1-induced apoptosis in which E2F1 directly represses Mcl-1 expression.

Citing Articles

Model scenarios for cell cycle re-entry in Alzheimer's disease.

Pandey N, Vinod P iScience. 2022; 25(7):104543.

PMID: 35747391 PMC: 9209725. DOI: 10.1016/j.isci.2022.104543.


Stress Relief Techniques: p38 MAPK Determines the Balance of Cell Cycle and Apoptosis Pathways.

Whitaker R, Cook J Biomolecules. 2021; 11(10).

PMID: 34680077 PMC: 8533283. DOI: 10.3390/biom11101444.


The Jieduan-Niwan (JDNW) Formula Ameliorates Hepatocyte Apoptosis: A Study of the Inhibition of E2F1-Mediated Apoptosis Signaling Pathways in Acute-on-Chronic Liver Failure (ACLF) Using Rats.

Hou W, Hao Y, Yang W, Tian T, Fang P, Du Y Drug Des Devel Ther. 2021; 15:3845-3862.

PMID: 34526765 PMC: 8436178. DOI: 10.2147/DDDT.S308713.


Understanding MCL1: from cellular function and regulation to pharmacological inhibition.

Sancho M, Leiva D, Lucendo E, Orzaez M FEBS J. 2021; 289(20):6209-6234.

PMID: 34310025 PMC: 9787394. DOI: 10.1111/febs.16136.


Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression.

Omori T, Tazawa H, Yamakawa Y, Osaki S, Hasei J, Sugiu K PLoS One. 2021; 16(4):e0250643.

PMID: 33886686 PMC: 8061981. DOI: 10.1371/journal.pone.0250643.